GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:

Needham

Research Company [hlAlert]
Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal
is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
URL : http://www.needhamco.com/Research.asp
  
Rating:
Buy LOCK
3 Months Gains
up 20.85 %

Rating:
Buy LOCK
3 Months Gains
up 14.28 %

Rating:
Buy LOCK
1 Week Gains
up 11.36 %

Rating:
Buy LOCK
1 Week Gains
up 6.62 %

Rating:
Buy CPHD
1 Month Gains
up 84.89 %
Cepheid (CPHD) upgraded to Buy with price target $44 by Needham
Thursday,  Dec 17, 2015  8:25 AM ET

Rating:
Buy CPHD
1 Month Gains
up 51.89 %
Cepheid (CPHD) upgraded to Buy with price target $44 by Needham
Thursday,  Dec 17, 2015  8:25 AM ET

Rating:
Buy CPHD
3 Months Gains
up 22.34 %
Cepheid (CPHD) upgraded to Buy with price target $44 by Needham
Thursday,  Dec 17, 2015  8:25 AM ET

Rating:
Buy CPHD
3 Months Gains
up 15.82 %
Cepheid (CPHD) upgraded to Buy with price target $44 by Needham
Thursday,  Dec 17, 2015  8:25 AM ET

Rating:
Buy CPHD
1 Month Gains
up 4.44 %
Cepheid (CPHD) upgraded to Buy with price target $44 by Needham
Thursday,  Dec 17, 2015  8:25 AM ET

Rating:
Buy CPHD
1 Week Gains
up 3.92 %
Cepheid (CPHD) upgraded to Buy with price target $44 by Needham
Thursday,  Dec 17, 2015  8:25 AM ET

Rating:
Buy FN
3 Months Gains
up 31.96 %
Fabrinet (FN) upgraded to Buy with price target $28 by Needham
Wednesday,  Dec 16, 2015  8:25 AM ET

Rating:
Buy FN
3 Months Gains
up 10.51 %
Fabrinet (FN) upgraded to Buy with price target $28 by Needham
Wednesday,  Dec 16, 2015  8:25 AM ET

Rating:
Buy FN
Fabrinet (FN) upgraded to Buy with price target $28 by Needham
Wednesday,  Dec 16, 2015  8:25 AM ET

Rating:
Buy AKBA
1 Day Gains
up 1.88 %

Rating:
Buy XCOM

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy